Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Kevzara Enrollment Form. For questions regarding the patient assistance program, please call. Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper.
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Dob (mm/dd/yyyy)* phone* zip code* insurance informationprimary rx insurance namerx insurance phone ( ) policy id # rx bin # patient has no insurance. Web prescription & enrollment form: Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Web patient consent and enrollment form instructions to ensure your information is processed without delay: Easily fill out pdf blank, edit, and sign them. Web complete kevzara enrollment form online with us legal forms. For questions regarding the patient assistance program, please call. Kevzara is used to treat adult patients with: Completesection 1 sign section 23. Approval press release you're invited to an expert data presentation on the kevzara indication for pmr.
Register today when it’s time for a change, target. Easily fill out pdf blank, edit, and sign them. Completesection 1 sign section 23. Save or instantly send your ready documents. Web complete kevzara enrollment form online with us legal forms. Patient’s irst name last name middle initial date of birth Web patient enrolment form for more information please contact: Please see important safety information including boxed warning, and full pi on website. Web patient consent and enrollment form instructions to ensure your information is processed without delay: All information will bekept confidential and will not be released to unauthorized parties without your consent. If you are applying forfinancial assistance 4.
